文献速递重症综合管理与镇静镇痛

非心脏手术术中血压管理:基于当前证据的叙述性综述

Intraoperative blood pressure management in noncardiac surgery: a narrative review based on current evidence.
PubMed 文献 · Intensive Care Med · 2026-02-17
一句话结论观察性与随机证据一致提示:多数非心脏手术患者术中平均动脉压维持在≥60–65 mmHg即可,单纯提高通用目标并未改善以患者为中心的结局。

该叙述性综述汇总了成人非心脏手术术中低血压、平均动脉压阈值及围术期器官损伤预防的观察性队列、随机对照试验、共识声明与新技术证据。大样本观察性数据显示平均动脉压60–70 mmHg与术后心肌损伤、急性肾损伤及死亡呈分级、持续时间依赖性关联,促成国际建议避免平均动脉压低于60–65 mmHg。然而纳入超过13,000例患者的多中心随机对照试验显示,与常规管理(通常平均动脉压≥65 mmHg)相比,追求更高或个体化平均动脉压阈值并未改善以患者为中心的结局,仅一项小型试验报告个体化收缩压目标获益。作者认为低血压反映异质性血流动力学内型,未来进展可能依赖机制分型与精准血流动力学策略,而非单纯提高通用平均动脉压目标。

要点

  • 观察性证据显示术中平均动脉压60–70 mmHg与术后心肌损伤、急性肾损伤及死亡呈分级、持续时间依赖性关联。
  • 国际建议避免平均动脉压低于60–65 mmHg;作者结论认为平均动脉压≥60–65 mmHg对多数非心脏手术患者似乎足够。
  • 纳入超过13,000例患者的多中心随机对照试验显示,更高或个体化平均动脉压目标与常规管理(通常平均动脉压≥65 mmHg)相比未改善以患者为中心的结局。
  • 仅一项小型试验报告个体化收缩压目标获益。
  • 持续血压监测、预防性去甲肾上腺素输注、预测分析与闭环升压药系统可可靠减少低血压暴露,但明确结局获益尚未证实。

适用人群与场景

  • 成人非心脏手术患者。

诊断标准与关键阈值

  • 国际建议避免术中平均动脉压低于60–65 mmHg。
  • 常规管理通常以平均动脉压≥65 mmHg为目标。

处置流程与药物剂量

  • 持续血压监测、预防性去甲肾上腺素输注、预测分析与闭环升压药系统可可靠减少低血压暴露,但明确结局获益尚未证实。

研究设计与关键结果

  • 大样本观察性数据集一致显示术中平均动脉压60–70 mmHg与术后心肌损伤、急性肾损伤及死亡呈分级、持续时间依赖性关联。
  • 当代多中心随机对照试验纳入超过13,000例患者,显示与常规管理(通常平均动脉压≥65 mmHg)相比,追求更高或个体化平均动脉压阈值未改善以患者为中心的结局。
  • 仅一项小型试验报告个体化收缩压目标获益。
  • 新兴证据提示低血压反映异质性血流动力学内型(血管扩张、低血容量、心肌抑制、心动过缓),可能解释统一压力目标未能改善结局。

证据类型、等级与局限

  • 证据类型:叙述性综述,汇总观察性队列研究、随机对照试验、共识声明与近期技术进展。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为平均动脉压≥60–65 mmHg对多数非心脏手术患者似乎足够,不应仅通过提高通用平均动脉压目标来改善结局。
  • 持续血压监测、预防性去甲肾上腺素输注、预测分析与闭环升压药系统可减少低血压暴露,但明确结局获益尚未证实。
  • 作者认为未来进展可能依赖机制内型分型、整合先进监测与精准指导的血流动力学策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Blood pressure is closely monitored during anaesthesia, yet the optimal intraoperative target remains uncertain. This narrative review synthesizes contemporary observational and randomized evidence and explores emerging strategies for individualized haemodynamic management.

METHODS: We reviewed major observational cohort studies, randomized controlled trials (RCTs), consensus statements, and recent technological developments addressing intraoperative hypotension, MAP thresholds, and strategies to prevent perioperative organ injury in adult noncardiac surgery.

RESULTS: Large observational datasets consistently demonstrate graded, duration-dependent associations between intraoperative MAP 60-70 mmHg and postoperative myocardial injury, acute kidney injury, and mortality . These findings have informed international recommendations to avoid MAP below 60-65 mmHg. However, contemporary multicentre RCTs enrolling more than 13,000 patients show that targeting higher or individualized MAP thresholds does not improve patient-centred outcomes compared with routine care (typically MAP ≥ 65 mmHg) . Only one small trial reported benefit with individualized systolic targets. Emerging evidence suggests that hypotension reflects heterogeneous haemodynamic endotypes (vasodilation, hypovolaemia, myocardial depression, bradycardia), potentially explaining why uniform pressure targets fail to improve outcomes. Continuous blood pressure monitoring, proactive norepinephrine infusion, predictive analytics, and closed-loop vasopressor systems reliably reduce hypotension exposure, although definitive outcome benefits remain unproven.

CONCLUSIONS: Observational and randomized data are concordant: MAP ≥ 60-65 mmHg appears sufficient for most noncardiac surgical patients. Future progress will likely depend on mechanistic endotyping, integration of advanced monitoring, and precision-guided haemodynamic strategies rather than escalation of universal MAP targets alone.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Joosten A, Chew MS, Futier E, et al. Intraoperative blood pressure management in noncardiac surgery: a narrative review based on current evidence. Intensive Care Med. 2026. PMID: 41701325. doi:10.1007/s00134-026-08326-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。